Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients

Effect of inflammatory cytokines

Divya Pankajakshan, Guanghong Jia, Iraklis Pipinos, Steve H. Tyndall, Devendra K. Agrawal

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. Methods and results: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-Α, IL-12 or IFN-Γ (50. ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1. Conclusion: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.

Original languageEnglish
Pages (from-to)280-286
Number of pages7
JournalExperimental and Molecular Pathology
Volume90
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Neuropeptide Y Receptors
Neuropeptide Y
Cytokines
Smooth Muscle Myocytes
Vascular Smooth Muscle
Muscle
Messenger RNA
Carotid Stenosis
Atherosclerotic Plaques
Carotid Arteries
Cells
Interleukin-12

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients : Effect of inflammatory cytokines. / Pankajakshan, Divya; Jia, Guanghong; Pipinos, Iraklis; Tyndall, Steve H.; Agrawal, Devendra K.

In: Experimental and Molecular Pathology, Vol. 90, No. 3, 06.2011, p. 280-286.

Research output: Contribution to journalArticle

Pankajakshan, Divya ; Jia, Guanghong ; Pipinos, Iraklis ; Tyndall, Steve H. ; Agrawal, Devendra K. / Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients : Effect of inflammatory cytokines. In: Experimental and Molecular Pathology. 2011 ; Vol. 90, No. 3. pp. 280-286.
@article{7abf37f81a944496bd70419dfa7ae328,
title = "Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: Effect of inflammatory cytokines",
abstract = "Aims: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. Methods and results: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-Α, IL-12 or IFN-Γ (50. ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1. Conclusion: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.",
author = "Divya Pankajakshan and Guanghong Jia and Iraklis Pipinos and Tyndall, {Steve H.} and Agrawal, {Devendra K.}",
year = "2011",
month = "6",
doi = "10.1016/j.yexmp.2011.02.005",
language = "English",
volume = "90",
pages = "280--286",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients

T2 - Effect of inflammatory cytokines

AU - Pankajakshan, Divya

AU - Jia, Guanghong

AU - Pipinos, Iraklis

AU - Tyndall, Steve H.

AU - Agrawal, Devendra K.

PY - 2011/6

Y1 - 2011/6

N2 - Aims: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. Methods and results: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-Α, IL-12 or IFN-Γ (50. ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1. Conclusion: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.

AB - Aims: Cytokines released by the immune cells at the site of plaque milieu induce smooth muscle cell apoptosis to promote plaque instability. But, neuropeptide Y (NPY), a pleotropic factor, may modulate the effects of cytokines in atherosclerotic plaques of patients with carotid stenosis. Our aim was to investigate the relative expression of NPY-Y1, NPY-Y2 and NPY-Y5 receptors on carotid plaque vascular smooth muscle cells (pVSMCs) of symptomatic (S) and asymptomatic (AS) patients and examine the effect of inflammatory cytokines on the expression of NPY receptors, that may attenuate plaque rupture. Methods and results: In healthy carotid artery, there were significantly increased immunopositivity and increased mRNA transcripts of NPY-Y1 and NPY-Y5 receptors in thin sections and isolated VSMCs, respectively, compared to S and AS plaques. However, the NPY-Y2 expression was higher in S and AS pVSMCs than controls. Stimulation of the cells with TNF-Α, IL-12 or IFN-Γ (50. ng/ml) decreased mRNA transcripts of NPY-Y1 and NPY-Y5 and increased NPY-Y2 mRNAs in VSMCs of healthy carotid artery. The effect of the cytokines on mRNA transcripts of NPY-Y5 and NPY-Y2 in pVSMCs of S and AS patients was similar to healthy VSMCs, but with variable effect on NPY-Y1. Conclusion: Increased expression of NPY-Y2 receptors in symptomatic pVSMCs than in healthy and asymptomatic subjects suggests a potential role of NPY-Y2 in plaque instability. This is further supported by the pronounced effect of atheroma-associated cytokines to increase NPY-Y2 mRNA transcripts in pVSMCs of patients with carotid stenosis.

UR - http://www.scopus.com/inward/record.url?scp=79952707522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952707522&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2011.02.005

DO - 10.1016/j.yexmp.2011.02.005

M3 - Article

VL - 90

SP - 280

EP - 286

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 3

ER -